Novavax CEO Stanley Erck's 2019 pay falls 41% to $2.4M
Novavax reports 2019 executive compensation
By ExecPay News
Published: May 12, 2020
Novavax reported fiscal year 2019 executive compensation information on May 12, 2020.
In 2019, four Novavax executives received on average a compensation package of $1.8M, a 14% decrease compared to previous year.
Average pay of disclosed executives at Novavax
Stanley C. Erck, Chief Executive Officer, received $2.4M in total, which decreased by 41% compared to 2018. 40% of Erck's compensation, or $987K, was in option awards. Erck also received $366K in non-equity incentive plan, $643K in salary, $432K in stock awards, as well as $11K in other compensation.
For fiscal year 2019, the median employee pay was $98,413 at Novavax. Therefore, the ratio of Stanley C. Erck's pay to the median employee pay was 25 to one.
Gregory M. Glenn, President, Research and Development, received a compensation package of $1.9M, which increased by 12% compared to previous year. 44% of the compensation package, or $819K, was in option awards.
John J. Trizzino, Chief Financial Officer, earned $1.5M in 2019, a 10% increase compared to previous year.
John A. Herrmann III, General Counsel, received $1.4M in 2019, which increases by 19% compared to 2018.
Related executives
You may also like
Source: SEC filing on May 12, 2020.